Letter to Editor

Veno-venous ECMO in patient with COVID-19 severe pneumonia

Volume: 42 Number: 1 May 20, 2020
Cumhuriyet Medical Journal Cover
Cumhuriyet Medical Journal
PDF Download
EN

Veno-venous ECMO in patient with COVID-19 severe pneumonia

Abstract

Since December 2019 we have been faced with a rapidly growing number of patients with COVID-19, which is caused by the SARS-CoV-2 coronavirus. According to the Centers for Disease Control and Prevention (CDC), COVID-19 is a respiratory illness. A person may have a dry cough, fever, muscle aches, and fatigue. Most common diagnosis for severe COVID-19 is severe pneumonia which may be life threatening . In most cases, antiviral, antimicrobial, and steroidal treatment is applied in these patients. However, some cases are resistant to treatment. Then the use of extracorporeal oxygenation membranes (ECMO) may be helpful.

Keywords

References

  1. 1. Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J 2020; 5(2); DOI: 10.5603/DEMJ.a2020.0012 2. Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0055. 3. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924 4. Smereka J, Puslecki M, Ruetzler K, et al. Extracorporeal membrane oxygenation in COVID-19. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0053. 5. Pravda NS, Pravda MS, Kornowski R, Orvin K. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic. Future Cardiol. 2020 Apr 17. doi: 10.2217/fca-2020-0040. 6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. . (accessed April 20, 2020) https://www.who.int/docs/default-source/coronaviruse/clinical-managementof-novel-cov.pdf. 7. Jacobs JP, Stammers AH, St Louis J. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. ASAIO J. 2020 Apr 17. doi: 10.1097/MAT.0000000000001185. 8. Burns KE, Adhikari NK, Slutsky AS, Guyatt GH, Villar J, Zhang H, Zhou Q, Cook DJ, Stewart TE, Meade MO. Pressure and volume-limited ventilation for the ventilatory management of patients with acute lung injury: a systematic review and meta-analysis. PLoS One. 2011;6:e14623. doi: 10.1371/journal.pone.0014623. 9. Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care. 2005;9:607–621. doi: 10.1186/cc3877.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Letter to Editor

Authors

Marek Dabrowski
0000-0003-1692-8578
Poland

Jacek Smereka
0000-0002-1427-4796
Poland

Anna Drozd
0000-0003-1949-4023
Poland

Publication Date

May 20, 2020

Submission Date

April 27, 2020

Acceptance Date

April 28, 2020

Published in Issue

Year 1970 Volume: 42 Number: 1

DOI

https://doi.org/10.7197/cmj.vi.728082

IZ

https://izlik.org/JA93EJ25CT

Cite

RIS / Bibtex
AMA
1.Dabrowski M, Smereka J, Evrin T, Katipoglu B, Drozd A, Szarpak L. Veno-venous ECMO in patient with COVID-19 severe pneumonia. CMJ. 2020;42(1):1-2. doi:10.7197/cmj.vi.728082